Abstract
Adrenoleukodystropy abbreviated as X-ALD is a serious genetic disorder that progressively affects the adrenal glands, the nervous system, and the spinal cord. The disorder was first identified in 1923 and was known as Schilder’s disease and later sudanophilic leukodystrophy. Dr. Michael Blaw renamed the disease to adrenoleukodystrophy in 1973. This was in recognition of the three main areas of the body that the disorder affects.
In this paper, we will examine various journals that cover the definition of the disease and its biochemistry. We will also examine the available approaches to treatment that patients are suffering from the
Continue reading...